These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1951685)

  • 1. Effects of recombinant IGF-I on protein and glucose metabolism in rTNF-infused lambs.
    Douglas RG; Gluckman PD; Breier BH; McCall JL; Parry B; Shaw JH
    Am J Physiol; 1991 Nov; 261(5 Pt 1):E606-12. PubMed ID: 1951685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.
    Douglas RG; Gluckman PD; Ball K; Breier B; Shaw JH
    J Clin Invest; 1991 Aug; 88(2):614-22. PubMed ID: 1864971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
    Mauras N; Horber FF; Haymond MW
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.
    Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO
    J Clin Invest; 1993 Jun; 91(6):2453-62. PubMed ID: 8514857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of insulin-like growth factor-I administration on the protein-sparing effects of total parenteral nutrition in fasted lambs.
    Koea JB; Douglas RG; Breier BH; Shaw JH; Gluckman PD
    Endocrinology; 1992 Aug; 131(2):643-8. PubMed ID: 1639012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circulating molecular weight forms of infused recombinant insulin-like growth factor-I and effects on glucose and fat metabolism in lambs.
    Douglas RG; Breier BH; Gallaher BW; Koea JB; Shaw JH; Gluckman PD
    Diabetologia; 1991 Nov; 34(11):790-5. PubMed ID: 1769436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
    Mauras N; Martinez V; Rini A; Guevara-Aguirre J
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.
    Mauras N; Martha PM; Quarmby V; Haymond MW
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E628-33. PubMed ID: 9142884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
    Mauras N; Beaufrere B
    J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
    Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.
    Chapman IM; Hartman ML; Pezzoli SS; Harrell FE; Hintz RL; Alberti KG; Thorner MO
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2996-3004. PubMed ID: 9284733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose and amino acid kinetic response to graded infusion of rhIGF-I in the late gestation ovine fetus.
    Liechty EA; Boyle DW; Moorehead H; Lee WH; Yang XL; Denne SC
    Am J Physiol; 1999 Sep; 277(3):E537-43. PubMed ID: 10484367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rhIGF-I infusion on whole fetal and fetal skeletal muscle protein metabolism in sheep.
    Boyle DW; Denne SC; Moorehead H; Lee WH; Bowsher RR; Liechty EA
    Am J Physiol; 1998 Dec; 275(6):E1082-91. PubMed ID: 9843752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
    Mauras N
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) on glucose and insulin levels in healthy males.
    Morgan JM; Piraino AJ; Saris SD; Capuzzi DM
    Int J Clin Pharmacol Ther; 1994 May; 32(5):235-9. PubMed ID: 7921517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N; Doi SQ; Shapiro JR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of insulin-like growth factor I on interorgan glucose and lactate flux in protein-catabolic dogs.
    Valentini L; Hölzenbein T; Winkler S; Sautner T; Ollenschläger G; Hörtnagl H; Karner J; Roth E
    J Surg Res; 1995 Nov; 59(5):606-13. PubMed ID: 7475008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.
    Chapman IM; Hartman ML; Pieper KS; Skiles EH; Pezzoli SS; Hintz RL; Thorner MO
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism.
    Boulware SD; Tamborlane WV; Matthews LS; Sherwin RS
    Am J Physiol; 1992 Jan; 262(1 Pt 1):E130-3. PubMed ID: 1733244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I inhibits degradation and improves retention of protein in hindlimb muscle of lambs.
    Oddy VH; Owens PC
    Am J Physiol; 1996 Dec; 271(6 Pt 1):E973-82. PubMed ID: 8997214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.